Literature DB >> 4833828

Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone.

T P Monath, V F Newhouse, G E Kemp, H W Setzer, A Cacciapuoti.   

Abstract

Lassa fever is a severe febrile illness of man, first recognized in West Africa in 1969. During an epidemic in Sierra Leone, Lassa virus was isolated for the first time from wild rodents of Mastomys natalensis. A high prevalence of infected Mastomys was found in houses occupied by patients with Lassa fever. The data presented provide the first demonstration of an extra-human cycle of Lassa virus transmission and suggest that rodent control may be an effective method of limiting the disease.

Entities:  

Mesh：

Year:  1974        PMID： 4833828     DOI： 10.1126/science.185.4147.263

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  110 in total

1.  Problems associated with the control of rodents in tropical Africa.

Authors:  N G Gratz; A A Arata
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Use of the complement fixation (CF) test in Lassa fever surveillance. Evidence for persistent CF antibodies.

Authors:  A Fabiyi; O Tomori
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

3.  Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification.

Authors:  Aiko Fukuma; Yohei Kurosaki; Yuko Morikawa; Allen Grolla; Heinz Feldmann; Jiro Yasuda
Journal:  Microbiol Immunol       Date:  2011-01       Impact factor: 1.955

4.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Authors:  Stefan Kunz; Jillian M Rojek; Mar Perez; Christina F Spiropoulou; Michael B A Oldstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 6.  Infectious diseases: fortieth and final annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

7.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Authors:  Igor S Lukashevich; Ricardo Carrion; Maria S Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

8.  An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome.

Authors:  Michaela Lelke; Linda Brunotte; Carola Busch; Stephan Günther
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis.

Authors:  D H Walker; H Wulff; J V Lange; F A Murphy
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.